Search Results - (Author, Cooperation:A. Vescovi)
-
1Y. Li ; N. T. Klena ; G. C. Gabriel ; X. Liu ; A. J. Kim ; K. Lemke ; Y. Chen ; B. Chatterjee ; W. Devine ; R. R. Damerla ; C. Chang ; H. Yagi ; J. T. San Agustin ; M. Thahir ; S. Anderton ; C. Lawhead ; A. Vescovi ; H. Pratt ; J. Morgan ; L. Haynes ; C. L. Smith ; J. T. Eppig ; L. Reinholdt ; R. Francis ; L. Leatherbury ; M. K. Ganapathiraju ; K. Tobita ; G. J. Pazour ; C. W. Lo
Nature Publishing Group (NPG)
Published 2015Staff ViewPublication Date: 2015-03-26Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Animals ; Cilia/genetics/*pathology/physiology/ultrasonography ; DNA Mutational Analysis ; Electrocardiography ; Exome/genetics ; Genes, Recessive ; Genetic Testing ; Heart Defects, Congenital/*genetics/*pathology/ultrasonography ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mutation/genetics ; Signal TransductionPublished by: -
2Leone, M ; Patruno, G ; Vescovi, A ; Bussone, G
USA/Oxford, UK : Blackwell Science Ltd
Published 1990Staff ViewISSN: 1468-2982Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Current views on cluster headache pathogenesis indicate a primary central nervous system dysfunction, in particular a hypothalamic involvement. To confirm the hypothalamic involvement in cluster headache we evaluated the hypothalamic-pituitary axis responsiveness with the thyrotrophin releasing hormone (TRH) test. A dose of 200 μg of TRH was administered i.v. to nine healthy controls, 32 patients with cluster headache during cluster period and 16 in remission period. Delta maximum thyrotrophin (TSH) was significantly lower in patients with cluster headache during cluster period (p 〈 0.05 versus healthy controls and cluster headache patients in remission). No difference was observed between healthy controls and cluster headache patients in remission. A monoaminergic dysfunction at the hypothalamic level is hypothesized.Type of Medium: Electronic ResourceURL: -
3Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cellsPiccirillo, S. G. M. ; Reynolds, B. A. ; Zanetti, N. ; Lamorte, G. ; Binda, E. ; Broggi, G. ; Brem, H. ; Olivi, A. ; Dimeco, F. ; Vescovi, A. L.
[s.l.] : Nature Publishing Group
Published 2006Staff ViewISSN: 1476-4687Source: Nature Archives 1869 - 2009Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsNotes: [Auszug] Transformed, oncogenic precursors, possessing both defining neural-stem-cell properties and the ability to initiate intracerebral tumours, have been identified in human brain cancers. Here we report that bone morphogenetic proteins (BMPs), amongst which BMP4 elicits the strongest effect, ...Type of Medium: Electronic ResourceURL: